Meta-analysis of these studies of 108,699 unselected breast cancer cases showed that 3.4% of breast cancers occurred in patients with a germline pathogenic variant of BRCA1 or BRCA2 (95% CI 2.5–4.7, Figure 1a, Supplementary Materials, Table S1). Here, BRCA2 is linked to breast carcinoma.